Supplementary Table S3 from Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S3. Ingenuity Canonical Pathways modulated by selamectin treatment
创建时间：
2015-08-01
